The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 06, 2026
Snapshot (as of Jul 06, 2026): Becton, Dickinson and Company (BDX) pays a $3.74 annual dividend ($1.05 quarterly), yielding 2.37% at $158.08/share. Next ex-dividend date 2026-06-09. 26 consecutive years of dividend growth (Dividend Aristocrat). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.37%
Annual Dividend: $3.74 per share
Payout Ratio: 104.1%
Ex-Dividend Date: 2026-06-09
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 45
Becton, Dickinson and Company dividend investors are looking at a global medical technology company that makes everything from IV catheters and insulin pen needles to diagnostic lab systems and surgical instrumentation. BDX currently pays a 2.4% dividend yield, with a trailing annual rate of $3.7428 per share paid quarterly, and the next ex-dividend date falls on June 9, 2026. The company has earned Dividend Aristocrat status with 26 consecutive years of dividend increases. A beta of 0.278 points to low price volatility, which suits income investors who prioritize steadiness over rapid capital appreciation.
Becton, Dickinson and Company pays out 104.1% of earnings as dividends, a payout ratio classified as high (above 75%). Becton, Dickinson and Company dividend safety rests on the breadth of its product portfolio: BD supplies essential, non-discretionary items like syringes, catheters, and diagnostic systems to hospitals, clinical labs, and pharmaceutical firms worldwide, which supports recurring demand. That said, a payout ratio above 100% means earnings alone do not currently cover the dividend, and any sustained pressure on profitability would put the payment under strain.
Becton, Dickinson and Company dividend history shows a CAGR of 6.7% per year from 2011 to 2025. The per-share annual dividend grew from $1.68 to $4.17 over that period (2026 data is partial and excluded from this calculation). The smallest annual increase in the window was 2.6% in 2019, which shows growth has not always been uniform.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +5.8% | $3.52 (2022) | $4.17 (2025) |
| 5-Year | +5.4% | $3.20 (2020) | $4.17 (2025) |
| 10-Year | +5.4% | $2.46 (2015) | $4.17 (2025) |
BDX fits dividend investors who want a Dividend Aristocrat in the healthcare sector with low price volatility and a multi-decade record of unbroken increases. The yield sits at a moderate (2–4%) 2.4%, nearly identical to its 5-year average of 2.39%, so there is no meaningful yield expansion on offer right now. Twenty-six consecutive years of increases is a real differentiator. The trade-off is a payout ratio above 100%, which means the dividend is not comfortably covered by current earnings. Income investors get a low-volatility, steadily growing payment from a company supplying essential medical products globally, but they accept meaningful payout pressure in exchange.
BDX is a Dividend Aristocrat with 26 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-06-09 | $1.0500 |
| 2026-03-10 | $1.0500 |
| 2025-12-08 | $1.0500 |
| 2025-09-08 | $1.0400 |
| 2025-06-09 | $1.0400 |
| 2025-03-10 | $1.0400 |
| 2024-12-09 | $1.0400 |
| 2024-09-09 | $0.9500 |
| 2024-06-10 | $0.9500 |
| 2024-03-07 | $0.9500 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.1000 |
| 2025 | $4.1700 |
| 2024 | $3.8900 |
| 2023 | $3.6800 |
| 2022 | $3.5200 |
Project income from BDX with the BDX dividend calculator or track your full portfolio with the dividend tracker.